Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 466

2.

Not 15 but 50% of smokers develop COPD?--Report from the Obstructive Lung Disease in Northern Sweden Studies.

Lundbäck B, Lindberg A, Lindström M, Rönmark E, Jonsson AC, Jönsson E, Larsson LG, Andersson S, Sandström T, Larsson K; Obstructive Lung Disease in Northern Sweden Studies.

Respir Med. 2003 Feb;97(2):115-22.

PMID:
12587960
[PubMed - indexed for MEDLINE]
3.

Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking Report from the Obstructive Lung Disease in Northern Sweden Studies.

Lindberg A, Bjerg A, Rönmark E, Larsson LG, Lundbäck B.

Respir Med. 2006 Feb;100(2):264-72. Epub 2005 Jun 21. Erratum in: Respir Med. 2007 Dec;101(12):2569. Bjerg-Bäcklund, Anders [corrected to Bjerg, A].

PMID:
15975774
[PubMed - indexed for MEDLINE]
Free Article
4.

The costs of exacerbations in chronic obstructive pulmonary disease (COPD).

Andersson F, Borg S, Jansson SA, Jonsson AC, Ericsson A, Prütz C, Rönmark E, Lundbäck B.

Respir Med. 2002 Sep;96(9):700-8.

PMID:
12243316
[PubMed - indexed for MEDLINE]
5.

Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages?

Rutten-van Mölken MP, Oostenbrink JB, Tashkin DP, Burkhart D, Monz BU.

Chest. 2006 Oct;130(4):1117-28.

PMID:
17035446
[PubMed - indexed for MEDLINE]
6.

Severity distribution of chronic obstructive pulmonary disease (COPD) in Dutch general practice.

Hoogendoorn M, Feenstra TL, Schermer TR, Hesselink AE, Rutten-van Mölken MP.

Respir Med. 2006 Jan;100(1):83-6.

PMID:
15894477
[PubMed - indexed for MEDLINE]
Free Article
7.

Obstructive lung disease in acute medical patients.

Seemungal T, Harrinarine R, Rios M, Abiraj V, Ali A, Lacki N, Mahabir N, Ramoutar V, King CP, Bhowmik A, Wedzicha JA.

West Indian Med J. 2008 Jan;57(1):7-13.

PMID:
19565931
[PubMed - indexed for MEDLINE]
8.

Newly diagnosed chronic obstructive pulmonary disease. Clinical features and distribution of the novel stages of the Global Initiative for Obstructive Lung Disease.

Kornmann O, Beeh KM, Beier J, Geis UP, Ksoll M, Buhl R; Global Initiative for Obstructive Lung Disease.

Respiration. 2003 Jan-Feb;70(1):67-75.

PMID:
12584394
[PubMed - indexed for MEDLINE]
Free Article
9.

[Prevalence and difficulties in chronic obstructive pulmonary disease diagnosis in patients suffering from severe peripheral arterial disease].

Sleszycka J, Woźniak K, Banaszek M, Wiechno W, Domagała-Kulawik J.

Pol Merkur Lekarski. 2009 Aug;27(158):92-6. Polish.

PMID:
19856871
[PubMed - indexed for MEDLINE]
10.

Characteristics of outpatients with COPD in daily practice: The E4 Spanish project.

Viejo-Bañuelos JL, Pueyo-Bastida A, Fueyo-Rodríguez A.

Respir Med. 2006 Dec;100(12):2137-43. Epub 2006 Jul 10.

PMID:
16831541
[PubMed - indexed for MEDLINE]
Free Article
11.

Pharmacoeconomic evaluation of COPD.

Hilleman DE, Dewan N, Malesker M, Friedman M.

Chest. 2000 Nov;118(5):1278-85.

PMID:
11083675
[PubMed - indexed for MEDLINE]
12.

Seven-year cumulative incidence of COPD in an age-stratified general population sample.

Lindberg A, Eriksson B, Larsson LG, Rönmark E, Sandström T, Lundbäck B.

Chest. 2006 Apr;129(4):879-85.

PMID:
16608933
[PubMed - indexed for MEDLINE]
13.

Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study.

Johannessen A, Omenaas ER, Bakke PS, Gulsvik A.

Thorax. 2005 Oct;60(10):842-7. Epub 2005 Aug 5.

PMID:
16085729
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study.

Jenkins CR, Jones PW, Calverley PM, Celli B, Anderson JA, Ferguson GT, Yates JC, Willits LR, Vestbo J.

Respir Res. 2009 Jun 30;10:59. doi: 10.1186/1465-9921-10-59.

PMID:
19566934
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

[The prevalence of chronic obstructive pulmonary disease (COPD) in Germany. Results of the BOLD study].

Geldmacher H, Biller H, Herbst A, Urbanski K, Allison M, Buist AS, Hohlfeld JM, Welte T.

Dtsch Med Wochenschr. 2008 Dec;133(50):2609-14. doi: 10.1055/s-0028-1105858. Epub 2008 Dec 3. German.

PMID:
19052996
[PubMed - indexed for MEDLINE]
16.

Inhaled corticosteroids and survival in COPD patients receiving long-term home oxygen therapy.

Tkacova R, Toth S, Sin DD.

Respir Med. 2006 Mar;100(3):385-92. Epub 2005 Aug 18.

PMID:
16105731
[PubMed - indexed for MEDLINE]
Free Article
17.

Prevalence, severity and underdiagnosis of COPD in the primary care setting.

Bednarek M, Maciejewski J, Wozniak M, Kuca P, Zielinski J.

Thorax. 2008 May;63(5):402-7. doi: 10.1136/thx.2007.085456. Epub 2008 Jan 30.

PMID:
18234906
[PubMed - indexed for MEDLINE]
18.

Severity of COPD at initial spirometry-confirmed diagnosis: data from medical charts and administrative claims.

Mapel DW, Dalal AA, Blanchette CM, Petersen H, Ferguson GT.

Int J Chron Obstruct Pulmon Dis. 2011;6:573-81. doi: 10.2147/COPD.S16975. Epub 2011 Nov 9.

PMID:
22135490
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Recent trends in physician diagnosed COPD in women and men in the UK.

Soriano JB, Maier WC, Egger P, Visick G, Thakrar B, Sykes J, Pride NB.

Thorax. 2000 Sep;55(9):789-94.

PMID:
10950900
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population.

Blanchette CM, Gutierrez B, Ory C, Chang E, Akazawa M.

J Manag Care Pharm. 2008 Mar;14(2):176-85.

PMID:
18331119
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk